Activities & Goals
Biomedical & Pharmaceutical Research
• Scientific Partnerships on innovative research ideas with clinics and laboratories of Greek Universities, the Greek National Health System and the private Hospital sector
• International Research Collaborations
• Experimental Projects of ELPEN with the General Secretariat for Research and Technology, the European Union and other bodies
• Preclinical (in vivo) Experimental Research on new molecules where ΕLPEN retains exclusive rights:
ΕLPEN is primarily interested in researching diseases that relate to the central nervous system, inflammation, the respiratory system and cardiology. The Center is fully equipped for preclinical studies on test molecules in the above categories. Note that in cardiology, in partnership with other, scientists have made use of the existing infrastructure to study the pharmacological effect of morpholine molecules on atherosclerosis. The studies were carried out on experimental animal models. Their results have been published in valid scientific journals.